Exploring the dNTP -binding site of HIV-1 reverse transcriptase for inhibitor design. 2021

Weijie Gu, and Sergio Martinez, and Abhimanyu K Singh, and Hoai Nguyen, and Jef Rozenski, and Dominique Schols, and Piet Herdewijn, and Kalyan Das, and Steven De Jonghe
KU Leuven, Department of Microbiology, Immunology and Transplantation, Rega Institute for Medical Research, Laboratory of Virology and Chemotherapy, Herestraat 49, 3000, Leuven, Belgium; KU Leuven, Department of Pharmaceutical and Pharmacological Sciences, Rega Institute for Medical Research, Laboratory of Medicinal Chemistry, Herestraat 49, 3000, Leuven, Belgium.

HIV-1 reverse transcriptase (RT) plays a central role in the viral life cycle, and roughly half of the FDA-approved anti-HIV drugs are targeting RT. Nucleoside analogs (NRTIs) require cellular phosphorylation for binding to RT, and to bypass this rate-limiting path, we designed a new series of acyclic nucleoside phosphonate analogs as nucleoside triphosphate mimics, aiming at the chelation of the catalytic Mg2+ ions via a phosphonate and/or a carboxylic acid group. Novel synthetic procedures were developed to access these nucleoside phosphonate analogs. X-ray structures in complex with HIV-1 RT/dsDNA demonstrated that their binding modes are distinct from that of our previously reported compound series. The impact of chain length, chirality and linker atom have been discussed. The detailed structural understanding of these new compounds provides opportunities for designing new class of HIV-1 RT inhibitors.

UI MeSH Term Description Entries
D008826 Microbial Sensitivity Tests Any tests that demonstrate the relative efficacy of different chemotherapeutic agents against specific microorganisms (i.e., bacteria, fungi, viruses). Bacterial Sensitivity Tests,Drug Sensitivity Assay, Microbial,Minimum Inhibitory Concentration,Antibacterial Susceptibility Breakpoint Determination,Antibiogram,Antimicrobial Susceptibility Breakpoint Determination,Bacterial Sensitivity Test,Breakpoint Determination, Antibacterial Susceptibility,Breakpoint Determination, Antimicrobial Susceptibility,Fungal Drug Sensitivity Tests,Fungus Drug Sensitivity Tests,Sensitivity Test, Bacterial,Sensitivity Tests, Bacterial,Test, Bacterial Sensitivity,Tests, Bacterial Sensitivity,Viral Drug Sensitivity Tests,Virus Drug Sensitivity Tests,Antibiograms,Concentration, Minimum Inhibitory,Concentrations, Minimum Inhibitory,Inhibitory Concentration, Minimum,Inhibitory Concentrations, Minimum,Microbial Sensitivity Test,Minimum Inhibitory Concentrations,Sensitivity Test, Microbial,Sensitivity Tests, Microbial,Test, Microbial Sensitivity,Tests, Microbial Sensitivity
D009711 Nucleotides The monomeric units from which DNA or RNA polymers are constructed. They consist of a purine or pyrimidine base, a pentose sugar, and a phosphate group. (From King & Stansfield, A Dictionary of Genetics, 4th ed) Nucleotide
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D001665 Binding Sites The parts of a macromolecule that directly participate in its specific combination with another molecule. Combining Site,Binding Site,Combining Sites,Site, Binding,Site, Combining,Sites, Binding,Sites, Combining
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D015195 Drug Design The molecular designing of drugs for specific purposes (such as DNA-binding, enzyme inhibition, anti-cancer efficacy, etc.) based on knowledge of molecular properties such as activity of functional groups, molecular geometry, and electronic structure, and also on information cataloged on analogous molecules. Drug design is generally computer-assisted molecular modeling and does not include PHARMACOKINETICS, dosage analysis, or drug administration analysis. Computer-Aided Drug Design,Computerized Drug Design,Drug Modeling,Pharmaceutical Design,Computer Aided Drug Design,Computer-Aided Drug Designs,Computerized Drug Designs,Design, Pharmaceutical,Drug Design, Computer-Aided,Drug Design, Computerized,Drug Designs,Drug Modelings,Pharmaceutical Designs
D015394 Molecular Structure The location of the atoms, groups or ions relative to one another in a molecule, as well as the number, type and location of covalent bonds. Structure, Molecular,Molecular Structures,Structures, Molecular
D015497 HIV-1 The type species of LENTIVIRUS and the etiologic agent of AIDS. It is characterized by its cytopathic effect and affinity for the T4-lymphocyte. Human immunodeficiency virus 1,HIV-I,Human Immunodeficiency Virus Type 1,Immunodeficiency Virus Type 1, Human
D054303 HIV Reverse Transcriptase A reverse transcriptase encoded by the POL GENE of HIV. It is a heterodimer of 66 kDa and 51 kDa subunits that are derived from a common precursor protein. The heterodimer also includes an RNAse H activity (RIBONUCLEASE H, HUMAN IMMUNODEFICIENCY VIRUS) that plays an essential role the viral replication process. Reverse Transcriptase, HIV,Reverse Transcriptase, Human Immunodeficiency Virus,Transcriptase, HIV Reverse
D018894 Reverse Transcriptase Inhibitors Inhibitors of reverse transcriptase (RNA-DIRECTED DNA POLYMERASE), an enzyme that synthesizes DNA on an RNA template. Reverse Transcriptase Inhibitor,Inhibitors, Reverse Transcriptase,Inhibitor, Reverse Transcriptase,Transcriptase Inhibitor, Reverse

Related Publications

Weijie Gu, and Sergio Martinez, and Abhimanyu K Singh, and Hoai Nguyen, and Jef Rozenski, and Dominique Schols, and Piet Herdewijn, and Kalyan Das, and Steven De Jonghe
September 2001, Biochemistry. Biokhimiia,
Weijie Gu, and Sergio Martinez, and Abhimanyu K Singh, and Hoai Nguyen, and Jef Rozenski, and Dominique Schols, and Piet Herdewijn, and Kalyan Das, and Steven De Jonghe
March 2000, Proceedings of the National Academy of Sciences of the United States of America,
Weijie Gu, and Sergio Martinez, and Abhimanyu K Singh, and Hoai Nguyen, and Jef Rozenski, and Dominique Schols, and Piet Herdewijn, and Kalyan Das, and Steven De Jonghe
May 1995, Biochemistry,
Weijie Gu, and Sergio Martinez, and Abhimanyu K Singh, and Hoai Nguyen, and Jef Rozenski, and Dominique Schols, and Piet Herdewijn, and Kalyan Das, and Steven De Jonghe
December 2010, Biochemistry,
Weijie Gu, and Sergio Martinez, and Abhimanyu K Singh, and Hoai Nguyen, and Jef Rozenski, and Dominique Schols, and Piet Herdewijn, and Kalyan Das, and Steven De Jonghe
October 2004, Current HIV research,
Weijie Gu, and Sergio Martinez, and Abhimanyu K Singh, and Hoai Nguyen, and Jef Rozenski, and Dominique Schols, and Piet Herdewijn, and Kalyan Das, and Steven De Jonghe
August 1994, Journal of medicinal chemistry,
Weijie Gu, and Sergio Martinez, and Abhimanyu K Singh, and Hoai Nguyen, and Jef Rozenski, and Dominique Schols, and Piet Herdewijn, and Kalyan Das, and Steven De Jonghe
December 1998, The Journal of biological chemistry,
Weijie Gu, and Sergio Martinez, and Abhimanyu K Singh, and Hoai Nguyen, and Jef Rozenski, and Dominique Schols, and Piet Herdewijn, and Kalyan Das, and Steven De Jonghe
February 1991, Biochemistry,
Weijie Gu, and Sergio Martinez, and Abhimanyu K Singh, and Hoai Nguyen, and Jef Rozenski, and Dominique Schols, and Piet Herdewijn, and Kalyan Das, and Steven De Jonghe
January 2016, Methods in molecular biology (Clifton, N.J.),
Weijie Gu, and Sergio Martinez, and Abhimanyu K Singh, and Hoai Nguyen, and Jef Rozenski, and Dominique Schols, and Piet Herdewijn, and Kalyan Das, and Steven De Jonghe
December 2004, Bioorganic & medicinal chemistry,
Copied contents to your clipboard!